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Abstract
Background: Birth cohort studies link gestational diabetes mellitus (GDM) with impaired cognitive performance in
the offspring. However, the mechanisms involved are unknown. We tested the hypothesis that obesity-associated
GDM induces chronic neuroinflammation and disturbs the development of neuronal circuitry resulting in impaired
cognitive abilities in the offspring.
Methods: In rats, GDM was induced by feeding dams a diet high in sucrose and fatty acids. Brains of neonatal
(E20) and young adult (15-week-old) offspring of GDM and lean dams were analyzed by immunohistochemistry,
cytokine assay, and western blotting. Young adult offspring of GDM and lean dams went also through cognitive
assessment. Cultured microglial responses to elevated glucose and/or fatty acids levels were analyzed.
Results: In rats, impaired recognition memory was observed in the offspring of GDM dams. GDM exposure combined
with a postnatal high-fat and sucrose diet resulted in atypical inattentive behavior in the offspring. These cognitive
changes correlated with reduced density and derangement of Cornu Ammonis 1 pyramidal neuronal layer, decreased
hippocampal synaptic integrity, increased neuroinflammatory status, and reduced expression of CX3CR1, the microglial
fractalkine receptor regulating microglial pro-inflammatory responses and synaptic pruning. Primary microglial cultures
that were exposed to high concentrations of glucose and/or palmitate were transformed into an activated, amoeboid
morphology with increased nitric oxide and superoxide production, and altered their cytokine release profile.
Conclusions: These findings demonstrate that GDM stimulates microglial activation and chronic inflammatory responses
in the brain of the offspring that persist into young adulthood. Reactive gliosis correlates positively with hippocampal
synaptic decline and cognitive impairments. The elevated pro-inflammatory cytokine expression at the critical period of
hippocampal synaptic maturation suggests that neuroinflammation might drive the synaptic and cognitive decline in the
offspring of GDM dams. The importance of microglia in this process is supported by the reduced Cx3CR1 expression as
an indication of the loss of microglial control of inflammatory responses and phagocytosis and synaptic pruning in GDM
offspring.
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Background
Gestational diabetes mellitus (GDM) is a state of glucose
intolerance and hyperglycemia with first onset during
pregnancy and is the most common complication of
pregnancy, affecting up to 10% of expectant mothers [1].
The prevalence of GDM is on the rise since more
women are overweight or obese when they become
pregnant. The combination of human cohort studies and
research using rodent models with controlled pre- and
postnatal conditions has demonstrated that diabetes dur-
ing pregnancy during critical stages of development af-
fects health outcomes in the offspring [2]. Several
human cohort studies have linked diabetes during preg-
nancy with impaired cognitive abilities [3–6] and psychi-
atric disorders [7, 8] in the offspring. Similar correlations
exist between poor quality early childhood diets and cog-
nitive performance [9, 10]. Brain development is particu-
larly sensitive to environmental influences during infancy
[11]. Animal studies utilizing controlled conditions con-
firmed that maternal high-sugar intake caused deficits in
cognitive functions in the offspring [12, 13]. However, the
mechanisms that link GDM to the development of cogni-
tive impairments in the offspring remain to be elucidated.
GDM is associated with mild but chronic systemic in-
flammation [14] and elevated circulating free fatty acids
[15, 16]. Although the transfer of cytokines across the
placenta from mother to fetus is restricted [17], maternal
hyperglycemia and hyperlipidemia directly impact the
fetus through the placental overproduction of pro-
inflammatory cytokines [14, 18]. We have also recently
shown that obesity-associated GDM promotes the pro-
duction of the pro-inflammatory cytokine, interleukin
(IL)-1β, and toll-like receptor activity, in the spleen cells
of neonatal and 15-week-old offspring that may contrib-
ute to chronic low-grade systemic inflammation [19].
Cytokines can induce pro-inflammatory responses in the
central nervous system (CNS) resulting in neuroinflam-
mation, which includes the release of cytokines, chemo-
kines, adhesion molecules, free radicals, and destructive
enzymes. Activation of microglia, resident brain immune
cells, is a central event and driving force in neuroinflam-
mation [20]. Pro-inflammatory responses of activated
microglia can jeopardize neurogenesis and promote neu-
rodegeneration [21]. Microglia have an important role in
neuroplasticity as they assist in the development and
maintenance of neuronal networks via trophic factor
release and controlled phagocytosis, which allows micro-
glia to prune synapses and remodel neuronal transmis-
sion [22, 23]. Microglial pro-inflammatory responses
[20] can also indirectly affect the neuronal vitality by
changing the function of astroglial cells, which have sup-
portive role in neuronal metabolism and modulation of
synaptic transmission [24]. GDM-induced inflammation
during embryogenesis could perturb microglial functions
resulting in a limited ability to support the development
of a healthy neuronal network that detrimentally influ-
ences brain development in the offspring.
We utilized a high-fat and sucrose (HFS) diet-induced
GDM model [19, 25] to evaluate the effects of GDM ex-
posure and postnatal diets on cognitive abilities and
neuroinflammation in the offspring. In this GDM model,
hyperglycemia is observed in mid-gestation and resolves
after the dam litters out, thus mimicking some features
of the clinical presentation of GDM in overweight and
obese women [19, 25]. We determined that GDM expos-
ure impaired recognition memory in the offspring and
when combined with postnatal HFS diet, resulted in
atypical inattentive behavior. These cognitive changes
were associated with reduced density and derangement
of the Cornu Ammonis 1 (CA1) pyramidal neuronal
layer, decreased hippocampal synaptic integrity, and
increased neuroinflammation. Exposure of primary cul-
tures of microglia to elevated levels of glucose and/or
fatty acids triggered pro-inflammatory responses capable
of disturbing development of neuronal circuitry and
functions, suggesting that gluco- and lipotoxicity con-
tribute to microglial-mediated neuroinflammation.
Methods
Materials
Cell culture reagents were obtained from ThermoFisher,
and all other reagents were from Sigma/Aldrich (St.
Louis, MO) except where otherwise stated.
Animal model
All animal procedures were approved by the Animal
Welfare Committee of the University of Manitoba which
follows the guidelines of the Canadian Council on
Animal Care and the Council for International Organi-
zations of Medical Sciences. Rats were given ad libitum
access to food and water and were housed two per cage.
As described previously [25], GDM was induced in fe-
male Sprague-Dawley rats using a high-fat and sucrose
diet (HFS; 45% fat, 4.73 kcal/gm, Research Diets
D12451; New Brunswick, NJ, USA) for 6 weeks prior
mating, throughout gestation and lactation, while lean
control dams were fed a low-fat diet (LF, 10% fat,
3.85 kcal/gm, Research Diets D12450B). All females
were mated with lean males. The dams experienced in-
creased weight gain during pregnancy and starting mid-
gestation developed hyperinsulinemia and moderate
hyperglycemia (Table 1). This model mimics clinical
symptoms of GDM seen in mothers as well as their
offspring that developed obesity and insulin resistance
[2, 25]. Litters were randomly reduced to eight pups in
order to avoid competition for food. The remaining off-
spring were weaned at 3 weeks of age, and males from
each litter were randomly assigned to a LF or HFS
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postnatal diet. This created four experimental groups: off-
spring from LF-fed dams (“lean”) that were fed a LF or
HFS postweaning diet and offspring from HFS-fed dams
(“GDM”) that were fed a LF or HFS postweaning diet. All
offspring underwent behavioral testing at 14 weeks of age
and were sacrificed at 15 weeks of age, as young adults,
when they were insulin resistant [25] but hyperglycemia
was not observed (Table 2). In addition, neonatal (E20)
offspring were collected for analysis.
Behavioral testing
Young adult rats had behavioral tests starting 1 week
prior their sacrifice to analyze whether GDM and/or
postweaning diet affected their cognition. The behavioral
tests focus on analyzing the anxiety, attention, explor-
ation, memory, and learning abilities. For the open field
(OF) test, an arena with walls to prevent escape was
used and the test was videotaped for later analysis to as-
sess general activity level, anxiety, attention, and explor-
ation tendency [26]. The rats were placed in OF (white
square plexiglass chamber; L 75 cm ×W 75 cm ×H
75 cm, illuminated at 8–13 lx red light) for 10 min.
Locomotor activity, rearing, and the amount of time
spent in the center area of the OF were calculated. The
novel object recognition (NOR) test of recognition
memory which is affected by hippocampal and perirhinal
cortex damage [27–31] was performed after the OF test.
On the first day, rats were placed back to the testing
arena which had now two identical objects. Rats were
allowed to explore the objects freely for a 10-min train-
ing session. On the second day, rats were placed back
into the testing arena for the 10-min test session, during
which they were presented with one of the objects used
during training (familiar object) and with a novel,
unfamiliar object of different shape and texture. Object
locations were kept constant during training and test
sessions for any given rat. Arenas and objects were
cleaned with 70% ethanol between each rat. Frequency
of object interactions and time spent exploring each ob-
ject was recorded with a HVS Image 2100 Plus video
tracking system software (HVS Image Ltd., Twickenham,
Middlesex, UK). Frequency of object interactions during
the first 5 min was used for analyses.
Brain immunostaining and cytokine measurements
Immunostaining was performed on 4% formaldehyde
fixed 30-μm coronal sections with anti-NeuN (Chemicon
international, 1:500), anti-synaptophysin (1:500), anti-Iba1
(Wako, 1:500), and anti-GFAP (EMD Millipore, 1:500)
followed by Dylight 488 or 594 conjugated anti-IgG
(Thermofisher, 1:500) as described previously [32]. ImageJ
program (NIH) was used to measure hippocampal neur-
onal CA1 layer thickness, and synaptophysin and GFAP
expressions were determined by the mean optical density
in the designated, uniform-sized regions of interest
[32, 33]. Microglial morphology identification was
based on assessment of cell soma and processes (Table 3).
Values were measured on a minimum of three matching
hippocampal regions from each rat, background values
were subtracted, and the resulting values were averaged to
give one value per rat.
For cytokine assays, the brain tissue (the whole neo-
natal hemisphere, forebrain hemisphere of young adult)
were homogenized 1:3 weight to volume in RIPA buffer
(Thermo Scientific) with complete protease inhibitor,
followed by centrifugation. Cytokines were analyzed in
100 μl aliquots of tissue homogenates using Rat Inflam-
mation antibody Array G1 (RayBiotech, Inc.) according
to the manufacturer’s instructions [32]. Values of the
cytokine assay were normalized to protein content of
tissue homogenate. The data is presented as a fold
change compared to control cohorts (lean or lean-LF).
Western blotting
Brain homogenates were analyzed by immunoblotting
on 8% SDS-PAGE gel with anti-CX3CR1 (Novus, 1:500
dilutions) and anti-β-actin (1;5000), followed by peroxidase-
conjugated anti-IgG (Vector Laboratories, Burlingame, CA,
1:5000 dilution). The protein bands were visualized using
ECL™ WB Detection kit (Amersham-Pharmacia Biotech)
and ChemiDoc MP imaging system (BioRad). Band
Table 2 Offspring blood glucose (at 15 weeks of age) and
weight gain (from weaning to 15 weeks of age)
Blood glucose (mmol/L) Postweaning weight gain (g)
Lean LF (6) 5.78 ± 0.55 557 ± 55.6
Lean HFS (8) 5.80 ± .0.22 568 ± 30.4
GDM LF (9) 5.92 ± 0.84 573 ± 63.8
GDM HFS (7) 5.43 ± 0.79 661 ± 57.7*
*p ≤ 0.05 compared to Lean LF
Table 1 Maternal gestational blood glucose (at 3rd week of
pregnancy) and weight gain during pregnancy
Blood glucose (mmol/L) Gestational weight gain (g)
Lean (4) 4.28 ± 0.38 133.6 ± 2.9
GDM (4) 6.40 ± 0.21* 155.5 ± 14.1*
*p ≤ 0.05 compared to Lean
Table 3 Microglial morphology analysis criteria
Ramified Hypertrophic Amoeboid
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densities were quantified with the ImageJ program.
The data is presented as a fold change compared to
control cohorts (lean-LF).
Cell cultures
Mixed glial cultures were prepared from corteces of new-
born CD-1 mice, as described previously [34]. Experi-
ments were performed in low-glucose (5.5 mM) minimal
essential medium (MEM), as a control “normoglycemic”
(NG), and 16.7 mM glucose was considered as high glu-
cose (HG). Palmitic (0.4 and 1.2 mM) and oleic acids (0.4
and 1.2 mM) were bound to 3% serum albumin bovine
(fatty acid free, low endotoxin), and thus, in all conditions,
MEM was supplemented with 3% BSA. The glucose and
fatty acid concentrations were chosen based on levels de-
tected in healthy vs. GDM and/or T2D patients [35, 36].
Superoxide, nitric oxide, and cytokine measurements
in vitro
Superoxide production was analyzed acutely within a
90-min incubation period with glucose and/or fatty
acids with dihydroethidium (dHEt; 1 μM) as described
previously [37]. The data is presented as a fold
change from baseline dHEt readings normalized to
control condition (NG) at the peak time of super-
oxide production (45–60 min). Nitric oxide (NO) pro-
duction was measured from cell culture medium with
Greiss reagent after 24 h of incubation in experimen-
tal conditions as previously described [32]. Cytokines
were analyzed in 100 μl aliquots of cell culture
medium using Mouse Inflammation antibody Array
G1 (RayBiotech, Inc.), detecting ten different pro- and
anti-inflammatory cytokines according to the manu-
facturer’s instruction. Values for NO and cytokine as-
says were normalized to the protein content of each
well. The data is presented as a fold change com-
pared to control levels (NG).
Statistical analysis
For in vivo studies, the n denotes the number of rats in
each group, which consisted of a minimum of four dif-
ferent litters. For cell culture studies, the n denotes the
number of independent experiments, each performed in
triplicate. All data are expressed as the mean ± SEM.
Microglial morphological changes were evaluated with
the Kruskal-Wallis test followed by Dunn’s test for mul-
tiple group comparisons. Statistical significance of neo-
natal data was evaluated by one-way ANOVA followed
by the Student-Newman-Keuls. All other data were com-
pared with two-way ANOVA followed by Bonferroni’s
post hoc test.
Results
Gestational diabetes mellitus and/or postnatal high-fat
and sucrose diet induce atypical inattentive behavior and
recognition memory impairment in offspring
Offspring of GDM dams were analyzed at 14–15 weeks
of age, which is equivalent to the young adult stage in
humans. At this age, the GDM offspring are overweight
(Table 2) and insulin resistant [25]. General and loco-
motor activity, as assessed by the OF test, was similar
between all groups of offspring (Fig. 1a, c, d). However,
significantly fewer rearing were observed by the GDM
offspring compared to the lean offspring (Fig. 1e). GDM
offspring fed a LF diet (GDM-LF) tended (p = 0.054) to
spend more time in the center than lean-LF and lean-
HFS offspring, while GDM offspring fed a HFS diet
(GDM-HFS) spend significantly more (p < 0.05) time in
the center of the field (Fig. 1b), indicating differences in
the exploration habits of the GDM offspring. Rodents
typically avoid being exposed to open space but prefer to
remain close to the walls as a thigmotactic response [38]
and actively observe their surroundings by rearing, sug-
gesting that the GDM-HFS offspring show reduced anx-
iety level and inattentive behavior as they explore the
center of the OF while not actively surveying their sur-
roundings as indicated by their reduced rearing. The
NOR test demonstrated that offspring of GDM dams
also had impaired recognition memory because they
spent equal time exploring both the familiar and
novel object, while lean offspring preferred to exam-
ine the novel object displaying healthy recognition
memory (Fig. 1f, g).
Gestational diabetes mellitus reduces CA1 neuronal and
synaptic integrity in offspring brain
Hippocampal damage is associated with a poor outcome
in the NOR test [30, 39]; thus, we performed immu-
nostaining to evaluate hippocampal neuronal and
synaptic integrity. A higher overall thickness of Neu-
N-immunoreactive cells was detected in the neuronal
CA1 layer of the GDM-HFS group compared to
GDM-LF and lean offspring controls (Fig. 2a, b) due
to elevated number of scattered neurons above the
organized pyramidal layer. In addition, the compact,
tightly connected pyramidal neuron layer was thinner
in the GDM-HFS offspring (Fig. 2c, d). Reduced
synaptophysin expression was observed in the CA1
and DG area of GDM offspring, compared to off-
spring of lean dams (Fig. 2e, f ). Synaptophysin was
also reduced in neonatal GDM offspring by 11.1 ± 3%
(p = 0.009, n = 7) when compared to offspring of lean
dams. The CA1 neuronal layer in neonatal offspring
could not be delineated as it is still organizing until
~P20 [40, 41]. However, we do not expect changes in
neuronal numbers based on the data collected at
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15 weeks of age, when only GDM-HFS diet resulted
in derangement in the CA1 neuronal layer. This sug-
gests that fetal GDM exposure conditions the cells
while the second stress induced by the postnatal HFS
diet causes derangement in the CA1 layer.
Gestational diabetes mellitus induces chronic inflammation
in the offspring brain
Since GDM can promote a pro-inflammatory environ-
ment [14], we evaluated activation of microglia, the
resident immune cells of the brain. Iba1 immunohisto-
chemical analysis of the hippocampi from neonates re-
vealed microglial morphological activation, as judged by
the reduced proportion of ramified microglia (lean 65 ±
11% vs GDM 19 ± 6%), and an increased proportion of
microglia exhibiting amoeboid morphology (lean 8 ± 2%
vs GDM 46 ± 8%) (Fig. 3a–c). Increased GFAP expres-
sion (Fig. 3d, e) in the GDM neonates indicated elevated
hippocampal astogliosis. Increased levels of pro-
inflammatory cytokines IFNγ, IL-1α, IL-4, MCP-1, and
TNFα were also observed in the brain of the neonatal
offspring of GDM dams (Fig. 3f ). Overall, our findings
show that GDM increased neuroinflammation status in
the neonatal offspring.
The microglial morphological transformation and astro-
gliosis observed in the GDM offspring persisted into
young adulthood (Fig. 4). A reduced proportion of rami-
fied microglia and increased hypertrophic microglia within
the hippocampus were observed in the lean-HFS group
(Fig. 4a, b). However, both GDM-LF and GDM-HFS
Fig. 1 Gestational diabetes mellitus induces atypically exploratory and inattentive behavior and impairs recognition memory in offspring. Behavioral
test analysis of 14- to 15-week-old rats. a, b Open field heat map demonstrates that GDM offspring on postnatal HFS diet stayed more in the center of
the field. #p < 0.05, compared to lean LF cohorts, n = 8–10. c–e GDM offspring also showed reduced rearing, but their moving activity was not different
from the lean offspring cohorts. f, g In NOR, GDM offspring failed to differentiate the familiar object from the novel object presented to them a day after
the training, while lean offspring spent significantly more time exploring the novel object on test day.*p < 0.05, n = 6–10
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groups exhibited reduced ramified microglia and in-
creased hypertrophic and amoeboid microglia indicating
neuroinflammation (Fig. 4a, b). Astrogliosis assessed by
GFAP staining was elevated in the lean-HFS, GDM-LF,
and GDM-HFS offspring groups (Fig. 4a, d). Interestingly,
increased hippocampal microglial numbers were observed
in the lean-HFS and the GDM-LF groups (32 ± 17.2 and
40 ± 17.7%, respectively), whereas the GDM-HFS group
exhibited a 20.4 ± 0.1% reduction in microglial numbers
compared to GDM-LF offspring (Fig. 4c). Microglial num-
bers in the GDM-HFS group were not below the levels
observed in lean-LF offspring. Cytokine analysis of the
young adults from the various groups did not reveal dras-
tic changes in levels of cytokines in the brain tissue
(Fig. 4e). Among pro-inflammatory cytokines measured,
only MCP-1 was elevated in the brain of lean-HFS off-
spring (Fig. 4e), whereas the anti-inflammatory cytokine,
IL-10 was increased in the brain of the both lean-HFS and
GDM-LF offspring groups (Fig. 4e).
GDM reduces microglial CX3CR1 levels
Since microglial morphological activation correlates with
CA1 neuronal derangement and reduction in synapto-
physin expression in the GDM offspring, we evaluated
whether GDM affects microglial CX3CR1 expression,
which has been suggested to have an important role in
regulation of microglial functions associated with resting
signals and phagocytosis [42, 43]. While a postnatal HFS
diet in lean offspring tended to reduce CX3CR1 expres-
sion in the brain (31.6 ± 9.3%, p = 0.055), GDM exposure
also tended to reduce CX3CR1 expression in LF-fed off-
spring (30.6 ± 10.5%, p = 0.057) and an additive effect of
GDM exposure and postnatal HFS diet consumption on
Fig. 2 Gestational diabetes mellitus reduces hippocampal synaptic protein expression and deranges CA1 neuronal layer, when combined with
postnatal HFS diet. a, b, e Micrographs of 15-week-old rat hippocampus with NeuN and synaptophysin. a–d NeuN staining did not show clear
reduction in neuronal numbers, but changes in CA1 pyramidal neuronal layer thickness and density were evident. e, f Hippocampal CA1 area in
GDM offspring had decreased synaptophysin expression suggesting decreased synaptic terminal integrity. *p≤ 0.05 compared to lean, n = 6
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CX3CR1 expression was observed in the GDM-HFS off-
spring (54.6 ± 7.3%, p = 0.015) (Fig. 4f, g).
High glucose and palmitic acid exposure stimulate pro-
inflammatory responses in primary microglial cultures
To test the hypothesis that GDM conditions and/or in-
dividual components of a HFS diet can trigger microglial
activation, primary microglia were cultured in elevated
glucose and palmitic acid concentrations that are similar
to levels observed in the circulation of patients with type 2
diabetes [44, 45]. High glucose (HG) stimulated microglial
transformation towards activated morphology (Fig. 5a).
Oleic acid, a monounsaturated fatty acid, promoted mor-
phological activation increasing the percentage of hyper-
trophic microglia, whereas palmitic acid, a saturated fatty
acid, increased the percentage of amoeboid microglia
(Fig. 5a) and overall microglial numbers (Fig. 5b). Interest-
ingly, the combination of HG and high palmitate (HP)
had the most profound effect on increasing the proportion
of activated microglia with amoeboid morphology. The
Fig. 3 Gestational diabetes mellitus induces neuroinflammation in the offspring brain (at 20E). Micrographs of immunostaining with Iba1 and
GFAP demonstrate elevated neuroinflammation status throughout the rat embryo brain. a, b Iba1 allows visualization of microglial morphology.
The microglia of embryos from GDM dams have more activated, amoeboid morphology compared to embryos from dams with healthy pregnancy of
which majority possess resting, ramified microglial morphology. d Increase in GFAP expression seen in embryos of GDM dams reflects on astroglial activation
and chronic inflammation. Quantitative analysis of hippocampal Iba1-positive cells (c) and GFAP staining (e) confirms the elevated neuroinflammation in
GDM offspring. f Cytokine analysis demonstrates increase in pro-inflammatory cytokines (IFNγ, TNFα, IL-1, MCP-1), while only IL-4 was elevated from the
anti-inflammatory cytokines (IL-4, IL-10, IL-13). *p≤ 0.05 compared to lean, n= 6
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combination of oleate and HG did not accentuate micro-
glial morphological activation (Fig. 5a). Microglial NO re-
lease was stimulated only by HP and no additive effect
was observed with HP and HG (Fig. 5c). Superoxide pro-
duction was increased by HG or HP, but additive effects of
HG and HP were not observed (Fig. 5d). Oleate did not
affect NO or superoxide production and the combination
of oleate with HG did not potentiate their production
(Fig. 5c, d). Microglial cytokine analysis revealed that HG
increased IL-1α release (Fig. 5e). Palmitate increased the
release of several pro-inflammatory cytokines (GM-CSF,
IL-1α, 1β, 2, 3, 9, 23, IFNγ, TNFα) as well as some anti-
inflammatory cytokines (IL-4, 10) and reduced IL-6 and
G-CSF release (Fig. 5e, f ). Oleic acid did not increase pro-
inflammatory cytokine release, but stimulated G-CSF and
IL-6 release (Fig. 5e, f ). Combined HP and HG exposure
Fig. 4 Gestational diabetes mellitus promotes neuroinflammation in offspring (at 15 weeks of age). a Micrographs of Iba1 and GFAP immunostainings
from 15-week-old rat hippocampi. b, c Iba1 staining allows visualization of microglial morphology and number of microglia/macrophages present in
the hippocampus. Microglia in offspring from lean dams possess resting, ramified morphology, whereas GDM exposure reduced microglial ramification,
as evident by increase in hypertrophic morphology and “fully activated” amoeboid morphology in GDM offspring brain. d GDM offspring also showed
increased GFAP expression which demonstrates astroglial activation upon GDM. e Cytokine analysis of 15-week-old rat brain cortical section including
the hippocampi, cortex, and hypothalamus does not indicate big changes in cytokine profiles between groups. f, g CX3CR1 expression was significantly
reduced in GDM-HFS offspring brain. #p≤ 0.05 compared to lean LF, *p≤ 0.05 as indicated, n= 6
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only increased IL-1α release and reduced IL-6, 13, and
G-CSF (Fig. 5e, f ). The combination of oleate and HG at-
tenuated the oleate-induced production of IL-6 (Fig. 5f).
Discussion
Neurons in the CNS require a healthy microenviron-
ment to survive, which is a central function of microglia,
the resident immune cells of the brain. In the adult
brain, microglia phagocytose invading pathogens and
clear away debris to maintain a healthy CNS. During
brain development in utero, microglia control the wiring
of the brain by performing synaptic pruning and assist-
ing in synapse maturation [23, 46]. Microglial phagocyt-
osis and cytokine release profile also affect neurogenesis
and neuronal viability [20, 46]. In obese adult humans
and rodents, a prolonged hypercaloric challenge coin-
cides with activation of microglia, which is initially tran-
sient but, when sustained, leads to detrimental effects on
the surrounding neurons [47].
Our data provides the first evidence that in the rat,
maternal obesity-associated GDM influences microglial
activation and neuroinflammation in newborn offspring.
Fig. 5 High glucose and palmitic acid exposure stimulates pro-inflammatory response in primary microglial cultures. a–f Responses of cultured
microglia exposed to conditions mimicking T2D; utilizing glucose and fatty acid levels find in T2D vs. healthy patients. High fat (HF; 1.2 mM palmitic
acid) alone and with elevated glucose (HG; 16.7 mM) induces microglial transformation towards activated amoeboid morphology (a), stimulates
microglial proliferation (b), triggers release of nitric oxide (NO) (c), production of superoxide (SO) (d), and alters pro-inflammatory (e) and
anti-inflammatory (b) cytokine release profiles in primary microglial cell cultures. #p≤ 0.05 compared to control (NG), *p ≤ 0.05 as indicated, n = 3-6
Vuong et al. Journal of Neuroinflammation  (2017) 14:80 Page 9 of 13
Moreover, we show for the first time that microglial acti-
vation in GDM offspring is sustained into young adult-
hood and is associated with astrogliosis and derangement
of the hippocampal CA1 layer. Interestingly, these alter-
ations in neuronal arrangement in the young adult GDM
offspring were associated with impaired recognition mem-
ory, reduced anxiety level, and inattentive behavior.
Therefore, offspring of GDM dams exhibit many of the
cognitive changes reported in some clinical cohort studies
of populations of children from mothers diagnosed with
diabetes during pregnancy [3–6].
Our study used obesity-associated GDM model, in
which dams are fed a diet enrich in high levels of fats
and simple sugars. The diet increased the weight of the
dams and caused a pregnancy-driven hyperglycemia and
hyperinsulinemia, as the glucose intolerance starts after
mid-pregnancy [19, 25]. The offspring of our GDM mice
have elevated weight gain and, at 15 weeks, show mild
insulin resistance, but no glucose intolerance or hyper-
glycemia [2, 25]. While these symptoms in both dams
and offspring are consistent with the clinical presenta-
tion of obesity-associated GDM, our GDM rat model
does not recapitulate all of the aspects of non-obese
GDM that has different etiology [48].
At present, little is known about how excess saturated
fats and simple sugars affect microglial activation.
Recent research has shown that high-glucose levels in-
crease microglial activation [49] and cytokine production
[50, 51]. Similarly, a diet rich in saturated fats [52] as
well as intracerebral ventricular injections of saturated
fatty acids [53] stimulated microglial activation and in-
flammatory responses. Previous clinical research [54, 55]
and results from experimental mouse models [56]
showed that diets high in saturated fat and simple sugars
lead to cognitive impairments. Obesity has also reported
to induce microglial activation and IL-1R-mediated defi-
cits in hippocampal synaptic plasticity in mice [57]. In
agreement with these findings, we observed elevated
neuroinflammatory status (microglial morphological ac-
tivation and astrogliosis) in lean-HFS offspring. We ex-
tend these findings to show for the first time that GDM
induced by a diet high in saturated fat and simple sugars
during pregnancy caused reactive gliosis and elevated
pro-inflammatory cytokine (IFN-γ, IL-1α, MCP-1, TNFα)
levels in the neonate offspring. Reactive gliosis was main-
tained until early adulthood; however, inflammatory cyto-
kine levels in the brain were not. Together, this data
suggested that fetal exposure to maternal obesity-
associated GDM induced robust neuroinflammation in
the offspring brain during the critical period of hippocam-
pal synaptic development (up to 3–4 weeks of age). Inter-
estingly, derangement of the CA1 pyramidal neurons and
behavioral changes in the GDM offspring were observed
only when a postnatal HFS diet was consumed, suggesting
that GDM conditions microglia to be in an activated state
and the addition of the HFS diet further damages the hip-
pocampal CA1 synaptic organization and maintenance.
Previous research using primary microglial cultures
showed that raising the glucose concentration from 25 to
50 mM or from 10 to 25 mM increased TNFα secretion
two- or [51] fourfold [50], respectively. However, 25 mM
glucose is rarely observed in the brain [44]. The glucose
levels in adult are about 70–80% lower in CSF than in
plasma and do not generally exceed 16.7 mM (300 mg/dl)
[58]. However, in neonates and infants, CSF/plasma ratio
is higher than in adults 0.88–1.1 [59]. As glucose levels
fluctuate due to feeding patterns, we decided to use a
5.5 mM (100 mg/dl) glucose as a normoglycemic condi-
tion and significantly higher, 16.7 mM glucose (300 mg/dl)
as a high-glucose condition in order to capture the fluctu-
ation maximum in these 24-hour microglial culture exper-
iments in order to assess the effects of gestational glucose
exposure. This glucose increase (from 5.5 to 16.7 mM)
stimulated morphological activation of microglia without
increasing TNFα production, nor other cytokines in gen-
eral. On the other hand, we observed that elevated palmi-
tate markedly stimulated microglial activation including
pro-inflammatory cytokine production, in agreement with
previous findings [52]. While the combination of HP and
HG triggered superoxide production and morphological
activation, it only increased IL-1α cytokine release,
whereas HP alone elevated most of the measured pro-
inflammatory cytokines. The combination of HP and HG
maintained anti-inflammatory cytokines at basal levels
(IL-4 and IL-10) or below (IL-13), while HP alone in-
creased IL-4 and 10 levels. While the fold changes in cyto-
kine levels in our study were not profound, the singular
cytokine levels may not be as crucial as the sum of the
changes in the whole cytokine profile. Based on these
findings, elevated saturated fatty acid concentrations ap-
peared to contribute a larger effect on microglial activa-
tion and neuroinflammation than elevated glucose levels.
This is not surprising given that microglia express the
toll-like receptor [53] as well as lipoprotein lipase and
acyl-CoA synthases that facilitate fatty acid uptake by cells
[51]. Nonetheless, additional studies are required to eluci-
date the effects of glucose and fatty acid supplementation
on microglial cytokine production.
While our study provides strong evidence that
microglial actions promote the pathological changes
in the hippocampus of GDM offspring, it is important
to keep in mind that these changes are likely multi-
factorial and represent a combination of elevated
maternal glucose, fatty acids, and inflammation/cyto-
kines. In fact, a HFS diet has been reported to reduce
hippocampal neuronal viability via affecting micro-
vascular insulin sensitivity [60] and fatty acids can be
directly neurotoxic [61, 62].
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Hippocampal microglial numbers were increased in
lean-HFS as well as GDM-LF offspring, while the com-
bination of GDM exposure and a HFS postnatal diet re-
duced microglial cell numbers. One explanation for this
observation is that the HFS diet promotes GDM induced
chronic microglial activation to a level where chronic
pro-inflammatory activation jeopardized microglial via-
bility. It has been postulated that microglial senescence
and lack of microglial supportive functions could lead to
neurodegeneration associated with various neurodegen-
erative diseases [63]. Cytokine analysis of the young
adults partially supports this notion, since IL-10, 4, and
13 levels were reduced in the GDM-HFS offspring com-
pared to the GDM-LF offspring.
An additional explanation for the cognitive deficits
seen in young adult GDM offspring was reduced levels
of synaptic proteins and a drastic decrease in microglial
expression of the fractalkine receptor, CX3CR1. The
fractalkine (CX3CL1)-CX3CR1 signaling axis promotes
microglial remodeling of synaptic circuits by regulating
microglial motility, trophic factor release, and phagocyt-
osis activity [43]. Microglial CX3CR1 expression in the
developing CNS is essential for hippocampal synapse
development [23], synaptic plasticity, and cognitive
functions [64]. In neurodegenerative disease models,
CX3CR1 depletion was reported to sustain microglial in-
flammatory responses and degrade synaptic circuits, thus
promoting neurodegeneration [65]. Our in vivo findings
are in line with these findings and reduced CX3CR1 ex-
pression provides a logical mechanistic explanation
linking microglial changes to hippocampal synaptic deg-
radation, neuronal derangement, and cognitive changes
in GDM offspring. A recent report further supports the
view that prenatal stress can program microglial CX3CR1
expression and promote microglial pro-inflammatory re-
sponses [66]. Given that neuroinflammation is largely
driven by microglia, and our data shows that GDM causes
microglial activation that is associated with hippocampal
neuronal weakening and cognitive deficits, a reduction in
microglial CX3CR1 expression could be central in the sus-
tained microglial activation observed in the 15-week-old
offspring of GDM dams.
Conclusions
Our findings suggested that obesity-associated GDM in-
duces neuroinflammation in offspring during the critical
period of hippocampal synaptic development dramatic-
ally affecting hippocampal neuronal synaptic integrity
and cognitive abilities. GDM exposure combined with
postnatal HFS feeding to the offspring induced further
hippocampal damage as indicated by the derangement of
hippocampal pyramidal neurons in the CA1 area.
Mechanistically, postnatal HFS diets and prenatal GDM
exposure induced reduced CX3CR1 expression that
could explain impaired microglial functions, prolonged
pro-inflammatory microglial responses, and uncon-
trolled synaptic phagocytosis. Therefore, microglial acti-
vation in the fetal brain could serve as an adaptive
response to elevated fatty acids and glucose during a
GDM pregnancy, which appears to condition microglia
to a neuroinflammatory environment such that sus-
tained exposure to postnatal HFS diet resulted in de-
rangement of the hippocampal CA1 pyramidal neurons
and cognitive impairments in young adulthood. Under-
standing the mechanisms responsible for the effects of
GDM on cognitive development in the offspring could
provide new ways to intervene and thus modify the neu-
rodevelopmental effects of GDM.
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